Meridian Bioscience reported $25M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbott ABT:US $ 17086M 210M
Accelerate Diagnostics AXDX:US 115.92M 7.94M
Atrion ATRI:US 0 0
Becton, Dickinson and BDX:US $ 17584M 1224M
Bio Rad Laboratories BIO:US $ 1196.74M 1186.22M
Cerulean Pharma CERU:US $ 0 0
Cerus CERS:US $ 54.77M 45K
Meridian Bioscience VIVO:US $ 25M 25M
Myriad Genetics MYGN:US $ 0M 0M
Orasure Technologies OSUR:US $ 1.21M 0.74M
Quidel QDEL:US $ 0M 0M
Sientra SIEN:US $ 65.58M 3.12M
Staar Surgical STAA:US $ 0.34M 0.04M
Thermo Fisher Scientific TMO:US $ 31389M 944M
Utah Medical Products UTMD:US 0 0